Sponsors (9)
Introduced June 18, 2025 by Bill Cassidy · Last progress June 18, 2025
The bill directs substantial, multi-year federal funding and expanded surveillance and service authority to strengthen overdose prevention, treatment, and workforce capacity — trading higher taxpayer cost, increased administrative and privacy concerns, and potential access or regulatory risks for broader and more sustained public-health response capabilities.
State, Tribal, and local governments plus nonprofits and service providers gain multi-year, higher federal funding authorizations (2026–2030) that provide predictable support for overdose-prevention, recovery, tribal, peer, and workforce programs.
Communities and health systems can address a wider range of overdose-causing substances (not just opioids) and use authorized, privacy-compliant surveillance tools (including wastewater) to detect emerging threats earlier.
Pregnant and postpartum people and others with substance use disorders will have expanded access to treatment and recovery supports (including increased residential treatment funding, expanded recovery-support activities, and loan repayment to recruit behavioral health clinicians).
Federal taxpayers face higher federal spending due to the expanded multi-year authorizations and increased program funding through 2026–2030.
Expanded surveillance tools (including wastewater monitoring) raise privacy and civil‑liberties concerns if data use, limits, or protections are not crystal clear and consistently enforced.
New reporting, mandated reviews, and program requirements create additional administrative burdens for States, Tribes, grantees, and HHS that could divert staff time and resources from direct service delivery.
Based on analysis of 8 sections of legislative text.
Broadens overdose programs beyond opioids, sets FY2026–2030 funding levels, increases treatment and workforce funds, expands surveillance and oversight, and tightens some controlled‑substance delivery rules.
Updates and reauthorizes multiple federal public-health programs that prevent and treat drug overdoses and substance use disorders. It broadens surveillance from opioids to all substances causing overdose, raises and specifies multi-year authorization levels for several programs, expands funding for residential treatment for pregnant and postpartum women and for workforce loan repayment, creates a regional technical assistance center with a required evaluation, and directs HHS to review certain drug product data with a possible request to the Attorney General on scheduling. The bill also tightens when pharmacies may deliver certain controlled substances to practitioners and makes technical adjustments to education and training rules for health professions.